Skip to content

Clinical trials

Completed Recurrence trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Status: Completed Country / region: Hong Kong Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20151
20161
20191
20202
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
The University of Hong Kong3
Novartis Pharmaceuticals2
Alexion Pharmaceuticals, Inc.1
Astellas Pharma Singapore Pte. Ltd.1
Eisai Inc.1
Pamela Youde Nethersole Eastern Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence12
Nasopharyngeal Carcinoma2
Nasopharyngeal Neoplasms2
Demyelinating Diseases1
Disorders of Sex Development1
Epstein-Barr Virus Infections1
Leukemia, Myeloid, Acute1
Mental Disorders1
Multiple Myeloma1
Myelitis, Transverse1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.